Mather Group, Llc. Roivant Sciences Ltd. Transaction History
Mather Group, Llc.
- $7.67 Billion
- Q4 2024
A detailed history of Mather Group, Llc. transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Mather Group, Llc. holds 13 shares of ROIV stock, worth $140. This represents 0.0% of its overall portfolio holdings.
Number of Shares
13Holding current value
$140% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding ROIV
# of Institutions
332Shares Held
505MCall Options Held
573KPut Options Held
739K-
Qvt Financial LP New York, NY65.8MShares$710 Million76.3% of portfolio
-
Sb Investment Advisers (Uk) LTD London, X062.1MShares$670 Million6.45% of portfolio
-
Viking Global Investors LP47.8MShares$516 Million1.91% of portfolio
-
Vanguard Group Inc Valley Forge, PA44.1MShares$476 Million0.01% of portfolio
-
Black Rock Inc. New York, NY35.4MShares$382 Million0.01% of portfolio
About Roivant Sciences Ltd.
- Ticker ROIV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 704,382,976
- Market Cap $7.6B
- Description
- Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...